Mesirow Financial Investment Management - Fixed Income’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-19,875	Closed	-$1.65M	–	25
2022 Q2	$1.65M	Buy	+19,875	New	+$1.65M	0.21%	108